세계의 COVID-19 진단약 시장 : 기술별, 제품별, 채널별, 국가별 예측 - 이그제큐티브 컨설턴트 가이드 첨부(2025-2029년)

COVID-19 Diagnostics. Global C19 Diagnostic Market Forecast by Technology, Product, Channel and Country. With Executive and Consultant Guides. 2025-2029

US $ 6,995 ￦ 9,633,000

PDF (Single User License)

PDF 보고서를 1명(One device)만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 10,495 ￦ 14,453,000

PDF (Five User License)

PDF 보고서를 동일 사업장의 5명(Five devices)까지 이용할 수 있는 라이선스입니다. 인쇄 불가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 13,995 ￦ 19,273,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄는 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

보고서 개요

팬데믹은 종식됐지만, COVID-19는 아직 종식되지 않았습니다. 호흡기 진단약의 매우 유리한 미래를 놓고 여러 경쟁자들이 경쟁하고 있습니다.

COVID-19 기반 진단약에 대한 새로운 역동적인 시장이 등장하고 있습니다. 검사는 의사의 진료실, 나아가 가정으로 옮겨가고 있습니다. 타액 검사, 휴대용 멀티플렉스 검사기, 가정용 테스트 스틱 등이 등장하고 있지만, 안전이 최우선시되는 작업장 시장은 어떻게 될까요? 그리고 팬데믹에 대응하기 위해 구축된 대규모 검사시설은? 이러한 시장의 변화에 대해 최신 보고서를 통해 확인할 수 있습니다.

기술별, 제품별, 채널별, 지역별, 지역별 매출에 대한 상세한 분석을 제공하는 이 완전한 보고서는 이 모든 것을 포괄하고 있습니다. 시장 가이드와 상황 분석을 통해 빠르게 상황을 파악할 수 있습니다.

요청에 따라 모든 보고서 데이터를 엑셀 형식으로 제공합니다. 최신 데이터를 사용하여 자신 있게 예측을 할 수 있습니다.

세계의 COVID-19 진단약 시장에 대해 조사했으며, 시장의 개요와 기술별, 제품별, 채널별, 국가별 동향 및 시장에 참여하는 기업의 개요 등을 제공하고 있습니다.

목차

제1장 시장 가이드

제2장 서론과 시장의 정의

• 팬데믹이란 무엇인가?
• 인수 공통 감염증의 역할
• 시장 정의
• 조사 방법
• 팬데믹의 역사적 시점

제3장 팬데믹의 개요

• 바이러스란 무엇인가?
• 코로나바이러스
• 팬데믹 진단

제4장 산업 구조

• 시장 참여 조직
  • 학술연구기관
  • 진단 시험 개발자
  • 계측 기기 공급업체
  • 약품·시약 제조업체
  • 병리 공급업체
  • 독립계 임상 검사실
  • 공공 국립/지역 연구소
  • 병원 검사실
  • 임상 검사실
  • 감사 기관
  • 인증 기관

제5장 진단 기업 개요

• Advanced Biological Laboratories
• Abbott Laboratories
• Accel Diagnostics
• Accelerate Diagnostics
• Access Bio
• ADT Biotech
• Agilent
• Altona Diagnostics
• Alveo Technologies
• Anatolia Geneworks
• Anitoa
• Applied BioCode
• Applied DNA Sciences
• Aureum Diagnostics
• Aurora Biomed
• Aus Diagnostics
• Autobio Diagnostics
• Autonomous Medical Devices
• Beckman Coulter Diagnostics(Danaher)
• Becton, Dickinson and Company
• BGI Genomics Co. Ltd.
• BillionToOne
• Binx Health
• Biocartis
• Biodesix Inc.
• BioFire Diagnostics(bioMerieux)
• BioGX
• Biolidics Ltd
• bioMerieux Diagnostics
• Bioneer Corporation
• Bio-Rad Laboratories, Inc
• Bio-Reference Laboratories
• Boditech Med, Inc
• Bosch Healthcare Solutions GmbH
• Celemics
• Cepheid(Danaher)
• Cerstest Biotec
• Chembio
• Co Diagnostics
• Color Genomics
• CTK Biotech
• Cube Dx
• Cue Health
• Curetis(OpGen)
• Detect
• Diagenode Diagnostics(Hologic)
• Diasorin S.p.A.
• Domus Diagnostics
• Ellume
• Enzo Biochem
• Everywell
• Fluxergy
• Fujirebio
• Fulgent Genetics
• Fusion Genomics.
• Fyr Diagnostics
• Genedrive
• Genetic Signatures
• GenMark Dx(Roche)
• Genomadix
• Gold Standard Diagnostics
• Hologic
• Illumina
• Immunexpress
• Inflammatix
• Innova Medical Group
• J&J Innovative Medicine
• Karius
• Laboratory Corporation of America
• Letsgetchecked
• LightDeck Diagnostics
• LumiraDx
• Mammoth Biosciences
• Mayo Clinic Laboratories
• Meep
• Meridian Bioscience
• Mesa Laboratories, Inc.
• Molbio Diagnostics
• NanoDx
• Nanomix
• Novacyt
• Nuclein
• OnsiteGene
• OraSure Technologies
• Oxford Nanopore Technologies
• Prenetics
• Primerdesign(Novacyt)
• Prominex
• Proof Diagnostics
• Qiagen
• QuantuMDx
• Quest Diagnostics
• QuidelOrtho
• Randox Toxicology
• R-Biopharm AG
• Revvity
• Roche Diagnostics
• Salignostics
• Scope Fluidics
• SD Biosensor
• Seegene
• Sekisui Diagnostics
• Sherlock Biosciences
• Siemens Healthineers
• Singular Genomics
• Sona Nanotech
• SpeeDx
• Standard BioTools
• Streamline Scientific
• Talis Biomedical
• Thermo Fisher Scientific
• Ultima Genomics
• Uniogen
• Vela Diagnostics
• Veredus Laboratories
• Vircell
• Visby Medical
• Wantai Biopharm
• YD Diagnostics
• Zhejiang Orient Gene Biotech

제6장 COVID-19 진단의 최근 동향

제7장 세계의 COVID-19 진단약 시장

• 국가별 세계 시장 개요
• 기술별 세계 시장 - 개요
• 제품별 세계 시장 - 개요
• 채널별 세계 시장 - 개요

제8장 세계의 COVID-19 진단약 시장 - 기술별

• PCR
• PCR 멀티플렉스
• 시퀀싱
• 항체
• 항원

제9장 세계의 COVID-19 진단약 시장 - 제품별

• 기기
• 시약과 키트
• 추출
• 수집

제10장 세계의 COVID-19 진단약 시장 - 채널별

• 공공
• 병원
• 클리닉
• 직장
• DTC/OTC
• 폐수

제11장 부록

KSA

영문 목차

영문목차

Report Overview:

The pandemic may be over but Covid-19 is here to stay. Multiple competitors are vying for the very lucrative future for respiratory diagnostics.

A new dynamic market is emerging for Covid - 19 based diagnostics. Testing is moving into physicians' offices and even into the home. Saliva tests? Handheld multiplex testers? Home based testing sticks? And what about the Workplace market where safety is paramount? And what happens to the large laboratory capacity that was built up to handle a pandemic now in decline? Learn all about these changing markets in our latest report.

Revenue, technology, products and channels. They are all looked at in this complete report that provides detailed breakdowns by country and regions. Get on top of the situation quickly with our Market Guides and Situation Analysis.

All report data is available in Excel format on request. Make projections with confidence using the latest data.

Table of Contents

1. Market Guides

• 1.1. Strategic Situation Analysis
• 1.2. Guidance for Executives
• 1.3. Guidance for Management Consultants and Investment Advisors

2. Introduction and Market Definition

• 2.1. What are Pandemics?
• 2.2. The Role of Zoonosis
• 2.3. Market Definition
  • 2.3.1. PCR
  • 2.3.2. PCR Multiplex
  • 2.3.3. SEQ
  • 2.3.4. Antigen
  • 2.3.5. Antibodies
  • 2.3.6. Instruments
  • 2.3.7. Reagents and Kits
  • 2.3.8. Extract
  • 2.3.9. Collect
  • 2.3.10. Public
  • 2.3.11. Hospital
  • 2.3.12. Clinic
  • 2.3.13. Workplace
  • 2.3.14. DTC/OTC
  • 2.3.15. Wastewater
• 2.4. Methodology
  • 2.4.1. Sources
  • 2.4.2. Authors
• 2.5. Historical Perspective on Pandemics
  • 2.5.1. HIV/AIDS PANDEMIC 2005-2012
  • 2.5.2. FLU PANDEMIC 1968
  • 2.5.3. ASIAN FLU 1956-1958
  • 2.5.4. SPANISH FLU 1918
  • 2.5.5. SIXTH CHOLERA PANDEMIC 1910-1911
  • 2.5.6. FLU PANDEMIC 1889-1890
  • 2.5.7. THE BLACK DEATH 1346-1353

3. The Pandemic Overview

• 3.1. What is a Virus?
  • 3.1.1. Is a Virus Alive?
  • 3.1.2. Viral Structure
  • 3.1.3. The Viral Genome
  • 3.1.4. Viral Mutation
• 3.2. The Coronavirus
  • 3.2.1. Severe acute respiratory syndrome (SARS)
  • 3.2.2. Middle East respiratory syndrome (MERS)
  • 3.2.3. COVID-19 The SARS CoV 2 Virus
    • 3.2.3.1. Signs and symptoms
    • 3.2.3.2. Transmission
    • 3.2.3.3. Diagnosis
    • 3.2.3.4. Prevention
    • 3.2.3.5. Management
    • 3.2.3.6. Prognosis
    • 3.2.3.7. A Note on Global Statistics Reporting
• 3.3. Pandemic Diagnostics
  • 3.3.1. Risk Management - Spark and Spread
  • 3.3.2. Dx Technology - Nucleic Acid Based
  • 3.3.3. Dx Technology - Immunoassay
  • 3.3.4. Time to Market and Preparedness Issues

4. Industry Structure

• 4.1. Players in a Dynamic Market
  • 4.1.1. Academic Research Lab
  • 4.1.2. Diagnostic Test Developer
  • 4.1.3. Instrumentation Supplier
  • 4.1.4. Chemical/Reagent Supplier
  • 4.1.5. Pathology Supplier
  • 4.1.6. Independent Clinical Laboratory
  • 4.1.7. Public National/regional Laboratory
  • 4.1.8. Hospital Laboratory
  • 4.1.9. Physicians Office Lab (POLS)
  • 4.1.10. Audit Body
  • 4.1.11. Certification Body

5. Diagnostic Company Profiles

• 5.1. Advanced Biological Laboratories
• 5.2. Abbott Laboratories
• 5.3. Accel Diagnostics
• 5.4. Accelerate Diagnostics
• 5.5. Access Bio
• 5.6. ADT Biotech
• 5.7. Agilent
• 5.8. Altona Diagnostics
• 5.9. Alveo Technologies
• 5.10. Anatolia Geneworks
• 5.11. Anitoa
• 5.12. Applied BioCode
• 5.13. Applied DNA Sciences
• 5.14. Aureum Diagnostics
• 5.15. Aurora Biomed
• 5.16. Aus Diagnostics
• 5.17. Autobio Diagnostics
• 5.18. Autonomous Medical Devices
• 5.19. Beckman Coulter Diagnostics (Danaher)
• 5.20. Becton, Dickinson and Company
• 5.21. BGI Genomics Co. Ltd.
• 5.22. BillionToOne
• 5.23. Binx Health
• 5.24. Biocartis
• 5.25. Biodesix Inc.
• 5.26. BioFire Diagnostics (bioMerieux)
• 5.27. BioGX
• 5.28. Biolidics Ltd
• 5.29. bioMerieux Diagnostics
• 5.30. Bioneer Corporation
• 5.31. Bio-Rad Laboratories, Inc
• 5.32. Bio-Reference Laboratories
• 5.33. Boditech Med, Inc
• 5.34. Bosch Healthcare Solutions GmbH
• 5.35. Celemics
• 5.36. Cepheid (Danaher)
• 5.37. Cerstest Biotec
• 5.38. Chembio
• 5.39. Co Diagnostics
• 5.40. Color Genomics
• 5.41. CTK Biotech
• 5.42. Cube Dx
• 5.43. Cue Health
• 5.44. Curetis (OpGen)
• 5.45. Detect
• 5.46. Diagenode Diagnostics (Hologic)
• 5.47. Diasorin S.p.A.
• 5.48. Domus Diagnostics
• 5.49. Ellume
• 5.50. Enzo Biochem
• 5.51. Everywell
• 5.52. Fluxergy
• 5.53. Fujirebio
• 5.54. Fulgent Genetics
• 5.55. Fusion Genomics.
• 5.56. Fyr Diagnostics
• 5.57. Genedrive
• 5.58. Genetic Signatures
• 5.59. GenMark Dx (Roche)
• 5.60. Genomadix
• 5.61. Gold Standard Diagnostics
• 5.62. Hologic
• 5.63. Illumina
• 5.64. Immunexpress
• 5.65. Inflammatix
• 5.66. Innova Medical Group
• 5.67. J&J Innovative Medicine
• 5.68. Karius
• 5.69. Laboratory Corporation of America
• 5.70. Letsgetchecked
• 5.71. LightDeck Diagnostics
• 5.72. LumiraDx
• 5.73. Mammoth Biosciences
• 5.74. Mayo Clinic Laboratories
• 5.75. Meep
• 5.76. Meridian Bioscience
• 5.77. Mesa Laboratories, Inc.
• 5.78. Molbio Diagnostics
• 5.79. NanoDx
• 5.80. Nanomix
• 5.81. Novacyt
• 5.82. Nuclein
• 5.83. OnsiteGene
• 5.84. OraSure Technologies
• 5.85. Oxford Nanopore Technologies
• 5.86. Prenetics
• 5.87. Primerdesign (Novacyt)
• 5.88. Prominex
• 5.89. Proof Diagnostics
• 5.90. Qiagen
• 5.91. QuantuMDx
• 5.92. Quest Diagnostics
• 5.93. QuidelOrtho
• 5.94. Randox Toxicology
• 5.95. R-Biopharm AG
• 5.96. Revvity
• 5.97. Roche Diagnostics
• 5.98. Salignostics
• 5.99. Scope Fluidics
• 5.100. SD Biosensor
• 5.101. Seegene
• 5.102. Sekisui Diagnostics
• 5.103. Sherlock Biosciences
• 5.104. Siemens Healthineers
• 5.105. Singular Genomics
• 5.106. Sona Nanotech
• 5.107. SpeeDx
• 5.108. Standard BioTools
• 5.109. Streamline Scientific
• 5.110. Talis Biomedical
• 5.111. Thermo Fisher Scientific
• 5.112. Ultima Genomics
• 5.113. Uniogen
• 5.114. Vela Diagnostics
• 5.115. Veredus Laboratories
• 5.116. Vircell
• 5.117. Visby Medical
• 5.118. Wantai Biopharm
• 5.119. YD Diagnostics
• 5.120. Zhejiang Orient Gene Biotech

6. Covid-19 Diagnostics Recent Developments

• 6.1. Recent Developments - Importance and How to Use This Section
  • 6.1.1. Importance of These Developments
  • 6.1.2. How to Use This Section
• 6.2. SEKISUI DX to Provide C19/Flu Test to the POC and Home Markets
• 6.3. Co-Diagnostics Submit Enhanced C19 Test
• 6.4. AI Blood Test Detects Long COVID with 93% Accuracy
• 6.5. Roche Diagnostics Growth Offset by COVID Sales Declines
• 6.6. Credo Preps MDx System, Multiplex Respiratory Test for US Launch
• 6.7. Acon Laboratories Gets FDA EAU for OTC COVID, Flu Test
• 6.8. Impact of Long COVID Revealed
• 6.9. QuidelOrtho Receives Clearance for Home COVID-19 Test
• 6.10. SEKISUI Dx Receives EAU for the OSOM-R Flu SARS-CoV-2 Combo Test
• 6.11. Johns Hopkins Shows COVID-19 Tests Done at Home Are Reliable
• 6.12. Walgreens Offers COVID-19 and Flu Testing
• 6.13. Home Test to Treat program extends nationwide
• 6.14. New test for long COVID Possible
• 6.15. Labcorp Gets Approval for Sequencing-Based COVID Test
• 6.16. Post-Pandemic, Patients Savvy About ID Diagnostics
• 6.17. Discover Labs Obtains EUA for RT-PCR COVID Test
• 6.18. Sensible Dx to Launch 10-Minute POC PCR System
• 6.19. Aptitude Medical Systems Aiming for At-Home Market
• 6.20. Qorvo To Emerge as More Than a COVID Company
• 6.21. End of COVID-19 Emergency Lowers Diagnostics Revenue
• 6.22. FDA Issues EUA for GenBody At-Home COVID Test
• 6.23. CTK Biotech Gets EAU for At-Home COVID Antigen Test
• 6.24. FDA Grants EAU for Premier Medical At-Home COVID Assay
• 6.25. QuidelOrtho Seeks Home Testing Contract
• 6.26. Aptitude Medical Gets EUA for Over-the-Counter COVID Saliva MDx
• 6.27. Siemens Healthineers Gains CE Marks for Seasonal Viral Assays
• 6.28. NanoDx Prepares for POC Platform Commercialization With TBI, COVID Tests
• 6.29. North American Dx Recalls Covid Rapid Antigen Tests
• 6.30. Domus Dx to Launch OC Diagnostics Test System
• 6.31. Becton Dickinson, ReturnSafe Collaborate on COVID-19 Testing
• 6.32. Mammoth Biosciences High-Throughput CRISPR-Based COVID Test Gets FDA EUA
• 6.33. At-Home COVID Test Coverage
• 6.34. LuminUltra Wins 500-Site CDC Wastewater Testing Contract
• 6.35. Sense Biodetection to Debut Instrument-Free Point-of-Care MDx
• 6.36. Tests Called Back

7. The Global Market for COVID-19 Diagnostics

• 7.1. Global Market Overview by Country
  • 7.1.1. Table - Global Market by Country
  • 7.1.2. Chart - Global Market by Country
• 7.2. Global Market by Technology - Overview
  • 7.2.1. Table - Global Market by Technology
  • 7.2.2. Chart - Global Market by Technology - Base/Final Year Comparison
  • 7.2.3. Chart - Global Market by Technology - Base Year
  • 7.2.4. Chart - Global Market by Technology - End Year
  • 7.2.5. Chart - Global Market by Technology - Share by Year
  • 7.2.6. Chart - Global Market by Technology - Segments Growth
• 7.3. Global Market by Product - Overview
  • 7.3.1. Table - Global Market by Product
  • 7.3.2. Chart - Global Market by Product - Base/Final Year Comparison
  • 7.3.3. Chart - Global Market by Product - Base Year
  • 7.3.4. Chart - Global Market by Product - End Year
  • 7.3.5. Chart - Global Market by Product - Share by Year
  • 7.3.6. Chart - Global Market by Product - Segments Growth
• 7.4. Global Market by Channel - Overview
  • 7.4.1. Table - Global Market by Channel
  • 7.4.2. Chart - Global Market by Channel - Base/Final Year Comparison
  • 7.4.3. Chart - Global Market by Channel - Base Year
  • 7.4.4. Chart - Global Market by Channel - End Year
  • 7.4.5. Chart - Global Market by Channel - Share by Year
  • 7.4.6. Chart - Global Market by Channel - Segments Growth

8. Global COVID-19 Diagnostic Markets - By Technology

• 8.1. PCR
  • 8.1.1. Table PCR - by Country
  • 8.1.2. Chart - PCR Growth
• 8.2. PCR Multiplex
  • 8.2.1. Table PCR Multiplex - by Country
  • 8.2.2. Chart - PCR Multiplex Growth
• 8.3. Sequencing
  • 8.3.1. Table Sequencing - by Country
  • 8.3.2. Chart - Sequencing Growth
• 8.4. Antibody
  • 8.4.1. Table Antibody - by Country
  • 8.4.2. Chart - Antibody Growth
• 8.5. Antigen
  • 8.5.1. Table Antigen - by Country
  • 8.5.2. Chart - Antigen Growth

9. Global COVID-19 Diagnostic Markets - By Product

• 9.1. Instruments
  • 9.1.1. Table Instruments - by Country
  • 9.1.2. Chart - Instruments Growth
• 9.2. Reagents & Kits
  • 9.2.1. Table Reagents & Kits - by Country
  • 9.2.2. Chart - Reagents & Kits Growth
• 9.3. Extraction
  • 9.3.1. Table Extraction - by Country
  • 9.3.2. Chart - Extraction Growth
• 9.4. Collection
  • 9.4.1. Table Collection - by Country
  • 9.4.2. Chart - Collection Growth

10. Global COVID-19 Diagnostic Markets - By Channel

• 10.1. Public
  • 10.1.1. Table Public - by Country
  • 10.1.2. Chart - Public Growth
• 10.2. Hospital
  • 10.2.1. Table Hospital - by Country
  • 10.2.2. Chart - Hospital Growth
• 10.3. Clinic
  • 10.3.1. Table Clinic - by Country
  • 10.3.2. Chart - Clinic Growth
• 10.4. Workplace
  • 10.4.1. Table Workplace - by Country
  • 10.4.2. Chart - Workplace Growth
• 10.5. DTC/OTC
  • 10.5.1. Table DTC/OTC - by Country
  • 10.5.2. Chart - DTC/OTC Growth
• 10.6. Wastewater
  • 10.6.1. Table Wastewater - by Country
  • 10.6.2. Chart - Wastewater Growth

11. Appendix

• 11.1. U.S., Europe, Asia Approved COVID-19 Assays

관련자료